Recent Updates
Recently added Catalysts
BDX Neutral Sentiment Score: 60/100

BD to Announce Financial Results for its First Quarter of Fiscal 2025 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio...

Key Takeaway: Becton, Dickinson and Company (BD) has announced plans to host an audio webcast on February 6, 2025, at 8 a.m. ET, to discuss its financial results for the first quarter of fiscal year 2025, which concluded on December 31, 2024. The company will provide updates regarding its operations and strategy during the session. Prior to the call, relevant financial information will be made available through a press release and presentation materials on its investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is a leading global medical technology company.
  • The company is hosting an upcoming audio webcast to discuss its financial results.
  • BD aims to enhance the safety and efficiency of healthcare delivery.

Full Press Release Details

FRANKLIN LAKES, N.J. , Jan. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, February 6, 2025 to discuss the Company's financial results for its first quarter of fiscal year 2025, which ended on December 31, 2024, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors , and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter. The news release and related presentation materials will be made available at www.bd.com/investors .
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD's audio webcast take place?

The audio webcast is scheduled for 8 a.m. ET on February 6, 2025.

Where can I access the BD audio webcast?

The webcast can be accessed at BD's investor relations website: www.bd.com/investors.

What will BD discuss in the February 2025 webcast?

BD will discuss its financial results for Q1 2025 and update its operations and strategy.

Will a replay of the webcast be available?

Yes, a replay will be available shortly after the call at the same website.

How many employees does BD have?

BD employs more than 70,000 individuals globally.

Last updated: Jan 16, 2025